Methyl formate → Methyl(2Z)-3-hydroxy-2-(1H-indol-1-ylmethyl)-2-propenoate
反応式
CC(C)([O-])C.[K+].[CH:7]([O:9][CH3:10])=[O:8].[N:11]1([CH2:20][CH2:21][C:22](OC)=[O:23])[C:19]2[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=2)[CH:13]=[CH:12]1>C1COCC1>[OH:23]/[CH:22]=[C:21](/[CH2:20][N:11]1[C:19]2[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=2)[CH:13]=[CH:12]1)\[C:7]([O:9][CH3:10])=[O:8]参加物
5
実験手順
To the suspension of potassium tert-butoxide (1.0 g, 8.91 mmol) in dry THF (10 mL) was added dropwise solution of methyl formate (1.0 ml, 16.22 mmol) and methyl 3-(1H-indol-1-yl)propanoate (1.0 g, 4.92 mmol) in dry THF over 30 min. The mixture was stirred at room temperature for 1 h. Concentration in vacuo then afforded the crude title compound (1.3 g). LCMS: rt=2.59 min, [M+H+]=232
後処理
- concentrationConcentration in vacuo
出典と根拠
- ORDレコード
- ord-703e82b5c2fd422394acab57b3968449
- 出典データセット
- uspto-grants-2014_01
- 特許番号
- US08637536B2
反応ノート
読み込み中…